Selective decreasing of amyloid- levels with small-molecule -secretase inhibitors is normally a appealing therapeutic approach for Alzheimers disease. in individual principal neuronal HEK and culture 293 cells [5]. L-685,458, an aspartyl protease changeover state mimic, decreased both A42 and A40 peptide development in SH-SY5Y, CHO and Neuro2a cells [6]. A large Stage III study happens… Continue reading Selective decreasing of amyloid- levels with small-molecule -secretase inhibitors is normally